MedTrace Logo

Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST

NCT02353052 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2015-02-02

No results posted yet for this study

Summary

Evaluate the reliability of morphology standards for GIST pathologic type, staging and grading by retrospective analyzing clinical data; on this basis, establish a GIST standardized and individualized treatment mode to maximum benefit GIST patients, avoid under- and over-treatment.

Conditions

  • Gastrointestinal Stromal Tumor

Interventions

OTHER

follow up

The patients were followed up for 3 years about their survival conditions and tumor status (eg. recurrence and metastasis).

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Yingyong Hou, Doctor · Shanghai Zhongshan Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02353052 on ClinicalTrials.gov